[Treatment of MSOF after heart valve replacement: an analysis of 53 cases]

J Mei1, B R Zhang, J L Zhu

  • 1Changhai Hospital, Second Military Medical University.

Insights

Multiple system organ failure (MSOF) after heart valve replacement impacts survival, with mortality increasing with more failing organs. Sequential organ failure yielded better outcomes than simultaneous failure.

Area of Science:

  • Cardiovascular Surgery
  • Critical Care Medicine
  • Transplantation Immunology

Context:

  • Multiple system organ failure (MSOF) is a critical complication following cardiac valve replacement surgery.
  • Understanding MSOF predictors and outcomes is crucial for improving patient management.
  • This study examines MSOF in 53 patients undergoing mitral valve replacement (MVR), aortic valve replacement (AVR), or double valve replacement (DVR).

Purpose:

  • To investigate the incidence, contributing factors, and outcomes of multiple system organ failure (MSOF) in patients post-heart valve replacement.
  • To identify correlations between MSOF severity, patient characteristics, and mortality.
  • To analyze the impact of different surgical procedures and organ failure patterns on patient survival.

Summary:

  • Of 53 patients experiencing MSOF post-heart valve replacement, 36 survived and 17 (32.1%) died.
  • Mortality positively correlated with the number of failing organs (up to 6) and was higher in patients with pre-operative NYHA functional class IV.
  • Sequential organ failure showed better outcomes than simultaneous failure; surgical type (MVR, AVR, DVR) did not significantly affect MSOF results.

Impact:

  • Findings highlight the critical role of the number and pattern of organ failure in MSOF prognosis after heart valve surgery.
  • Identifies pre-operative functional class as a significant factor influencing MSOF outcomes.
  • Provides insights into managing MSOF, emphasizing the importance of early intervention and supportive care in critical care settings.

Related Concept Videos

Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
239
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
229
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
423
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
261
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
273
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
397